THE LNCRNA SIGNATURE ASSOCIATED WITH CUPROPTOSIS AS A NOVEL BIOMARKER OF PROGNOSIS IN IMMUNOTHERAPY AND DRUG SCREENING FOR CLEAR CELL RENAL CELL CARCINOMA

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma

Cuproptosis is a new form of cell death, the second form of metal ion-induced cell death defined Table Set after ferroptosis.Recently, cuproptosis has been suggested to be associated with tumorigenesis.However, the relationship between cuproptosis and patient prognosis in clear cell renal cell carcinoma (ccRCC) in the context of immunotherapy remai

read more